tiprankstipranks
Trending News
More News >
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Compare Climb Bio (CLYM) vs. Competitors

Compare
660 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$3.96
$270.01M
-5.02
88.50%
3 Buy
0 Hold
0 Sell
Strong Buy
Agenus
$4.68
$159.16M
-1.73
16.09%
1 Buy
0 Hold
0 Sell
Moderate Buy
TuHURA Biosciences
$0.76
$45.95M
-1.17
-84.10%
2 Buy
0 Hold
0 Sell
Moderate Buy
Ovid Therapeutics
$1.65
$117.50M
-3.11
108.94%
8 Buy
0 Hold
0 Sell
Strong Buy
Cognition Therapeutics
$1.42
$125.35M
-2.91
95.47%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tevogen Bio Holdings
$0.32
$63.16M
-1.84
-73.92%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLYM
Climb Bio
3.77
1.76
87.56%
AGEN
Agenus
3.68
0.53
16.83%
HURA
TuHURA Biosciences
0.76
-3.97
-83.93%
OVID
Ovid Therapeutics
1.59
0.86
117.81%
CGTX
Cognition Therapeutics
1.38
0.69
100.00%
TVGN
Tevogen Bio Holdings
0.33
-0.88
-73.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts